cysteine has been researched along with Diabetic Angiopathies in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chao, ML; Chen, H; Chen, J; Han, Y; Ji, Y; Kong, C; Lin, Z; Luo, S; Sun, JP; Sun, S; Tang, X; Wang, D; Wang, H; Wang, J; Xie, L; Zhang, C; Zhou, M; Zhou, X | 1 |
Bull, R; Croad, JL; Jain, SK; Rains, JL; Velusamy, T | 1 |
Chang, TS; Jeong, W; Rhee, SG; Woo, HA | 1 |
1 review(s) available for cysteine and Diabetic Angiopathies
Article | Year |
---|---|
Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance.
Topics: Cysteine; Diabetic Angiopathies; Humans; Hydrogen Peroxide; Molecular Chaperones; Oxidation-Reduction; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; Peroxidases; Peroxiredoxins | 2007 |
2 other study(ies) available for cysteine and Diabetic Angiopathies
Article | Year |
---|---|
S-nitrosylation-mediated coupling of G-protein alpha-2 with CXCR5 induces Hippo/YAP-dependent diabetes-accelerated atherosclerosis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Atherosclerosis; Cells, Cultured; Cysteine; Diabetes Mellitus, Experimental; Diabetic Angiopathies; GTP-Binding Protein alpha Subunit, Gi2; Hippo Signaling Pathway; Human Umbilical Vein Endothelial Cells; Humans; Male; Melatonin; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Nitric Oxide Synthase Type II; Nitroso Compounds; Protein Serine-Threonine Kinases; Receptors, CXCR5; Transcription Factors; YAP-Signaling Proteins | 2021 |
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats.
Topics: Adiponectin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Biomarkers; Cell Line; Chromium; Coordination Complexes; Cysteine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Dietary Supplements; Humans; Hypoglycemic Agents; Liver; Male; Monocytes; Organometallic Compounds; Oxidative Stress; Random Allocation; Rats; Rats, Zucker; Signal Transduction | 2010 |